| Dr Sumit Mukherjee, MD | |
|
1 Edmundson Pl, Ste. 306, Council Bluffs, IA 51503-4658 | |
| (712) 396-7787 | |
| (712) 396-4115 |
| Full Name | Dr Sumit Mukherjee |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 14 Years |
| Location | 1 Edmundson Pl, Council Bluffs, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154647568 | NPI | - | NPPES |
| 10026209700 | Medicaid | NE | |
| 1154647568 | Medicaid | IA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Methodist Jennie Edmundson | Council bluffs, IA | Hospital |
| Cass County Memorial Hospital | Atlantic, IA | Hospital |
| Myrtue Medical Center | Harlan, IA | Hospital |
| Montgomery County Memorial Hospital | Red oak, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Physicians Clinic Inc | 4880506062 | 497 |
News Archive
Talecris Biotherapeutics announced today that the U.S. Food and Drug Administration (FDA) approved Gamunex-C (Immune Globulin Injection [Human], 10% Caprylate/Chromatography Purified) for subcutaneous administration in the treatment of primary immunodeficiency (PI).
Amorfix Life Sciences, a company focused on treatments and diagnostics for misfolded protein diseases, today announced it has achieved 100% specificity (no reproducible false positive results) upon testing 19,000 blood donations for variant Creutzfeldt-Jakob Disease ("vCJD") with the EP-vCJD(TM) Blood Screening Assay at l'Etablissement Français du Sang de Pyrénées Méditerrannée ("EFS-PM") in Montpellier, France.
A study conducted by researchers at the Johns Hopkins Malaria Research Institute and their Zambian colleagues detected contrasting patterns of drug resistance in malaria-causing parasites taken from both humans and mosquitoes in rural Zambia.
To ensure health reform works for those with the most at stake, the National Partnership for Women & Families, Community Catalyst and the National Health Law Program today launched the Campaign for Better Care, a multi-year initiative that will focus on improving health care quality, coordination and communication for older patients with multiple health problems and their family caregivers.
Seizures in people with epilepsy are commonly treated with anti-epileptic drugs (AEDs) but 30-40 percent do not achieve adequate seizure control, predisposing them to severe health risks, impaired quality of life and higher healthcare costs.
› Verified 5 days ago
| Entity Name | Physicians Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821049156 PECOS PAC ID: 4880506062 Enrollment ID: O20040129000296 |
News Archive
Talecris Biotherapeutics announced today that the U.S. Food and Drug Administration (FDA) approved Gamunex-C (Immune Globulin Injection [Human], 10% Caprylate/Chromatography Purified) for subcutaneous administration in the treatment of primary immunodeficiency (PI).
Amorfix Life Sciences, a company focused on treatments and diagnostics for misfolded protein diseases, today announced it has achieved 100% specificity (no reproducible false positive results) upon testing 19,000 blood donations for variant Creutzfeldt-Jakob Disease ("vCJD") with the EP-vCJD(TM) Blood Screening Assay at l'Etablissement Français du Sang de Pyrénées Méditerrannée ("EFS-PM") in Montpellier, France.
A study conducted by researchers at the Johns Hopkins Malaria Research Institute and their Zambian colleagues detected contrasting patterns of drug resistance in malaria-causing parasites taken from both humans and mosquitoes in rural Zambia.
To ensure health reform works for those with the most at stake, the National Partnership for Women & Families, Community Catalyst and the National Health Law Program today launched the Campaign for Better Care, a multi-year initiative that will focus on improving health care quality, coordination and communication for older patients with multiple health problems and their family caregivers.
Seizures in people with epilepsy are commonly treated with anti-epileptic drugs (AEDs) but 30-40 percent do not achieve adequate seizure control, predisposing them to severe health risks, impaired quality of life and higher healthcare costs.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sumit Mukherjee, MD Po Box 3755, Omaha, NE 68103-0755 Ph: (402) 354-2100 | Dr Sumit Mukherjee, MD 1 Edmundson Pl, Ste. 306, Council Bluffs, IA 51503-4658 Ph: (712) 396-7787 |
News Archive
Talecris Biotherapeutics announced today that the U.S. Food and Drug Administration (FDA) approved Gamunex-C (Immune Globulin Injection [Human], 10% Caprylate/Chromatography Purified) for subcutaneous administration in the treatment of primary immunodeficiency (PI).
Amorfix Life Sciences, a company focused on treatments and diagnostics for misfolded protein diseases, today announced it has achieved 100% specificity (no reproducible false positive results) upon testing 19,000 blood donations for variant Creutzfeldt-Jakob Disease ("vCJD") with the EP-vCJD(TM) Blood Screening Assay at l'Etablissement Français du Sang de Pyrénées Méditerrannée ("EFS-PM") in Montpellier, France.
A study conducted by researchers at the Johns Hopkins Malaria Research Institute and their Zambian colleagues detected contrasting patterns of drug resistance in malaria-causing parasites taken from both humans and mosquitoes in rural Zambia.
To ensure health reform works for those with the most at stake, the National Partnership for Women & Families, Community Catalyst and the National Health Law Program today launched the Campaign for Better Care, a multi-year initiative that will focus on improving health care quality, coordination and communication for older patients with multiple health problems and their family caregivers.
Seizures in people with epilepsy are commonly treated with anti-epileptic drugs (AEDs) but 30-40 percent do not achieve adequate seizure control, predisposing them to severe health risks, impaired quality of life and higher healthcare costs.
› Verified 5 days ago
Anand Deshmukh, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Edmundson Pl, Ste. #306, Council Bluffs, IA 51503 Phone: 712-396-7787 Fax: 712-396-4115 | |
John W Marshall, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 201 Ridge St, Suite 202, Council Bluffs, IA 51503 Phone: 712-325-0022 Fax: 712-325-8102 | |
Dr. Erica K. Cichowski, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1702 N 16th St, Council Bluffs, IA 51501 Phone: 712-256-7223 Fax: 712-256-7669 | |
Dr. Vikrant Salaria, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 800 Mercy Dr, Suite 120, Council Bluffs, IA 51503 Phone: 712-388-2770 Fax: 712-388-2771 | |
Dr. Kevin Crowley, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1 Edmundson Pl, Suite 310, Council Bluffs, IA 51503 Phone: 712-396-4300 Fax: 712-396-7069 | |
Christopher J Holewinski, RP, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 800 Mercy Dr, Council Bluffs, IA 51503 Phone: 712-328-5490 Fax: 712-325-2499 | |
Dr. Kalpana Kumar Puri, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 201 Ridge St Ste 312, Council Bluffs, IA 51503 Phone: 712-322-5532 Fax: 712-309-0193 |